Compounds > abiraterone
Page last updated: 2024-09-04

abiraterone and Cancer of Salivary Gland

abiraterone has been researched along with Cancer of Salivary Gland in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaev, I; Brennan, PA; Chhikara, R; Dabab, N; Fonseca, F; Gomez, RS; Rahimi, S; Rigby, E; Yeoh, CC1
Bossi, P; Civelli, E; Cortelazzi, B; Imbimbo, M; Licitra, L; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P; Rinaldi, G1
Angel, C; D'Costa, I; Rischin, D; Solomon, B; Urban, D1

Other Studies

3 other study(ies) available for abiraterone and Cancer of Salivary Gland

ArticleYear
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2018, Volume: 47, Issue:7

    Topics: Adenocarcinoma; Administration, Oral; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Female; Humans; Male; Molecular Targeted Therapy; Nitriles; Phenylthiohydantoin; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds

2018
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.
    Cancer biology & therapy, 2014, Jun-01, Volume: 15, Issue:6

    Topics: Adenocarcinoma; Adult; Androgen Antagonists; Androstenes; Androstenols; Anilides; Antineoplastic Agents, Hormonal; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2014
Abiraterone in metastatic salivary duct carcinoma.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2015, Volume: 13, Issue:3

    Topics: Androstenes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Salivary Ducts; Salivary Gland Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2015